New

Explore professionally built ETF model portfolios. Discover now →

Advertisement
Advertisement

ARKGvsLFSCETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.01%
VS
ETF 2
LFSC

F/m Emerald Life Sciences Innovation ETF

This fund is part of
Life Sciences
+0.39%

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. F/m Emerald Life Sciences Innovation ETF (LFSC) is part of the Life Sciences segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, LFSC's top sector exposures are Health Care and Sovereign. ARKG is less expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.79% for LFSC. ARKG is down -2.36% year-to-date (YTD) with -$17M in YTD flows. LFSC performs better with 4.23% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of ARKG and LFSC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs LFSC performance and flow charts

Performance

0510152025%Mar 30Apr 7Apr 14Apr 21Apr 28

Cumulative Flows

-80 M-60 M-40 M-20 M0 M20 MMar 30Apr 7Apr 14Apr 21Apr 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/29/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
LFSC
+14.98%+9.29%
-9.13%+4.98%
-2.36%+4.23%
+27.92%+64.72%
-2.43%n/a
-67.96%n/a
Flows
ARKG
LFSC
-$2M+$81K
-$53M+$6M
-$17M+$5M
-$66M+$15M
-$583M-
-$3.03B-
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
LFSC
+43.08%+28.86%
+41.66%+26.32%
+42.62%n/a
+45.37%n/a
Max drawdown
ARKG
LFSC
-20.97%-10.65%
-27.52%-16.25%
-51.98%n/a
-80.16%n/a
Max drawdown duration
ARKG
LFSC
90d47d
97d142d
1015dn/a
1765dn/a
Trading data

Create an account to view trading data

Join for free
ARKG
LFSC
Last sale
5/1/2026 at 1:30 PM
$30.30
$38.15
Previous close
04/29/2026
$29.87
$38.03
Consolidated volume
04/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Advertisement
Main metrics
Last update 5/1/2026 at 1:30 PM
Live
Closed
ARKG
LFSC
Last price
$30.30
$38.15
1D performance
+1.44%
+0.34%
AuM$1.13 B$101.77 M
E/R0.75%0.79%
Characteristics
ARKG
LFSC
Management strategyActiveActive
ProviderArk InvestmentEmerald Group
Benchmark--
N° of holdings2733
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019October 31, 2024
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
70.4%
Switzerland
9.23%
Other
20.37%
LFSC
USA
90.82%
United Kingdom
7.06%
Other
2.12%

Sectors

ARKG
Health Care
78.38%
Other
21.62%
LFSC
Health Care
78.16%
Other
21.84%
Advertisement

Diversification

ARKG

Total weight of top 15 holdings out of 15

62.5%
LFSC

Total weight of top 15 holdings out of 15

69.28%

Top 15 holdings

Data as of March 31, 2026
ARKG
CRISPR THERAPEUTICS
9.23%
10X GENOMICS INC
6.30%
BEAM THERAPEUTICS
4.86%
PERSONALIS INC
4.69%
NATERA
4.48%
ILLUMINA
4.45%
GUARDANT HEALTH INC
4.21%
INTELLIA THERAPEUTICS INC
3.58%
CAREDX INC/D
3.56%
RECURSION PHARMACEUTICALS
3.54%
ABSCI
3.27%
VERACYTE INC/D
2.98%
ADAPTIVE BIOTECHNOLOGIES
2.71%
NURIX THERAPEUTICS
2.45%
SEMA4 HOLDINGS CORP
2.19%
LFSC
COGENT BIOSCIENCES
9.11%
LIVANOVA
7.06%
UTD THERAPEUT
5.61%
US00773J2024
5.14%
MIRUM PHARMACEUTICALS INC
5.09%
TRAVERE THERAPEUTICS INC
4.75%
KALVISTA PHARMACEUTICALS INC
4.74%
GUARDANT HEALTH INC
4.38%
BRIDGEBIO PHARMA
4.05%
US6402683063
3.78%
TRANSMEDICS GROUP
3.77%
SAVARA INC
3.74%
TREVI THERAPEUTICS
2.95%
ICU MEDICAL
2.79%
AXSOME THERA CMN STK
2.32%
Frequently asked questions about ARKG and LFSC

How have the ARKG and LFSC ETFs performed in 2026?

As of April 29, 2026, ARKG is down -2.36% year-to-date (YTD), while LFSC has returned 4.23%. That puts LFSC better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or LFSC?

Year-to-date, the ARKG ETF saw -$17M in flows, compared to +$5M for LFSC.

Which ETF is more volatile: ARKG or LFSC?

Over the past year, ARKG had a volatility of 41.66%, while LFSC experienced 26.32%.

Which ETF is bigger: ARKG or LFSC?

As of April 29, 2026, ARKG holds $1.13 B in assets under management (AUM), while LFSC manages $101.77 M.

What sectors do the ARKG and LFSC ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, LFSC focuses on Health Care.

What are the top holdings of the ARKG ETF and LFSC ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. LFSC holds in its top three: COGENT BIOSCIENCES, LIVANOVA and UTD THERAPEUT.

Which ETF is more diversified: ARKG or LFSC?

ARKG holds 27 securities with 62.5% of its assets in the top 15. LFSC has 44 securities and a top 15 weight of 69.28%.

Advertisement
Latest news about ARKG & LFSC
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder